Alexandria Cherry will join the National Board of Directors for Dream Foundation, the only national dream-granting organization for terminally ill adults and their families.

Cherry will work with staff and fellow board members in their efforts to raise awareness and funding to provide end-of-life dreams that provide inspiration, comfort, and closure.
“I chose to become involved with Dream Foundation because I believe one of the greatest gifts we can give is our time, and to be of service to others which aligns with the mission of Dream Foundation,” Cherry said.

She is currently the vice president, Emerging Markets Group Lead (EMGL), for Rare Disease at Pfizer, Inc., where she develops and implements the commercial strategy for the rare disease portfolio across the Emerging Markets and China.

Cherry most recently was vice president of Pfizer Oncology’s Hematology Franchise, responsible for growing the portfolio of transformative medicines for people affected by blood cancers. Before joining Pfizer in 2017, she worked in various roles including marketing, sales, and finance for Eisai Inc., Cephalon and Johnson & Johnson.
“We are humbled to welcome Alex to our board,” said Kisa Heyer, Dream Foundation’s CEO. “Her dedication to those with cancer and rare diseases, makes her particularly qualified and knowledgeable about our dream recipients, their diseases, and their desire to dream again.”

“Having worked in the cancer field over the last 20-plus years, with the goal of bringing lifesaving treatments to those in need, I have learned that isn’t always feasible,” Cherry said. “My work with Dream Foundation is a call to serve those individuals that unfortunately couldn’t be saved by fulfilling a Dream during the time they have left.”

In addition to her inspiring work, Alex is an active member for the Healthcare Businesswomen’s Association (HBA.) In 2017, she received the HBA Rising STAR award for her leadership, innovation, and passion for helping to improve the lives of people living with cancer.

To support Dream Foundation’s mission, visit